In patients receiving checkpoint inhibitor therapy, modifications in RECIST tumor measurements are linearly correlated with survival.

Published Date: 07 Jun 2023

Objective tumor response is categorized into one of four categories using the Response Evaluation Criteria In Solid Tumors (RECIST) in many clinical trials to assess changes in tumor burden over time.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Q&A: When will individuals be able to receive customized cancer vaccines?

2.

Canadian Group Calls for Earlier Colorectal Cancer Screening

3.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

4.

Researchers achieve a significant milestone in the management of anemia in chronic lymphocytic leukemia.

5.

Talquetamab Combos Show Survival Benefit in r/r Myeloma


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot